NCT04811274View on ClinicalTrials.gov

Macrophages, GM-CSF and MARS Proteinosis

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

November 6, 2021

Study Completion Date

November 6, 2021

Conditions
Pulmonary Alveolar Proteinosis (PAP)MARSGenetic Mutation
Interventions
BIOLOGICAL

Blood collection

2 to 5 ml

BIOLOGICAL

Bronchoalveolar lavage fluid collection

5 to 25 ml

Trial Locations (1)

75015

Hôpital Necker-Enfants Malades, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER